KFDA, Case Forwarded with Recommendations for Indictment
Decision to Seize Assets Worth 220 Million Won,
▲ Baekok Biosell Inner Care. Provided by KFDA, ‘Three individuals were caught selling unapproved medical products as if they had therapeutic effects.’,
,
, “The Korea Food and Drug Administration (KFDA) announced on the 24th that they had apprehended three individuals for manufacturing and selling unapproved products. These individuals were charged with violating the Pharmaceutical Affairs Act and the Act on the Aggravated Punishment of Specific Crimes and were forwarded to the prosecution with recommendations for indictment.”,
,
, ‘To prevent the recurrence of similar crimes, the KFDA has also decided to seize assets related to the crime, amounting to approximately 220 million won.’,
,
, ‘According to reports, the KFDA began an investigation upon receiving information that unauthorized products were being manufactured and sold for purposes like treating incontinence.’,
,
, “According to the KFDA, suspect A and suspect B produced 1,500 boxes of the unapproved ‘Baekok Biosell Inner Care’ from May to November last year. They sold the products in their entirety to suspect C for approximately 250 million won, while claiming the products had therapeutic effects for incontinence and other conditions, along with product description materials and brochures.”,
,
, ‘Suspect C sold a total of 786 boxes, from July last year to March this year, both through door-to-door and online sales, at a price about four times the purchase cost, approximately 700,000 won per box, totaling around 520 million won.’,
,
, ‘C, in particular, promoted the products by recruiting testers three times, claiming they could be applied or ingested for treating diseases like incontinence and skin diseases on body parts such as eyes, nose, and anus, and posted testimonials and videos on the internet.’,
,
, ‘The KFDA reported that cases of side effects such as headaches, abdominal pain, and fever were also noted in these user testimonials.’,
,
, ‘The KFDA stated, “We plan to strengthen supervision and investigation against illegal drug manufacturing and sales, which threaten public health. Through stringent punishments, including the retrieval of crime proceeds, we aim to create an environment where citizens can safely use pharmaceuticals.” \n’]